ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ACNS1221: A Phase II Study for the Treatment of Non-Metastatic Nodular Desmoplastic Medulloblastoma In Children Less Than 4 Years of Age
Protocol ID
ACNS1221
Condition/s
Medulloblastoma
Diagnosis Stage
New diagnosis
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
External Registry ≫
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 47 Months
International registry ID's
NCT02017964
Back to Registry
Study Title ACNS1221: A Phase II Study for the Treatment of Non-Metastatic Nodular Desmoplastic Medulloblastoma In Children Less Than 4 Years of Age
Protocol ID ACNS1221
Disease (Sub Disease) Medulloblastoma
Diagnosis Stage New diagnosis
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT02017964
Trial Status Closed to Recruitment
Trial Open Date 22/04/2014
Study Type Treatment
Phase Phase 2
Age Eligibility up to 47 Months
International registry ID's NCT02017964

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.